Home / Companies / Lifecore Biomedical, Inc. / 7 Nov 2024
Lifecore Biomedical, Inc.: meeting of 7 Nov 2024
Votes reported on Form N-PX, item by item
128 Form N-PX filers reported votes at the Lifecore Biomedical, Inc. meeting of 7 Nov 2024. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
4 nominees; 75.3% of reported votes for; 37 filers withheld from or voted against at least one nominee.
312 vote records from 46 filers. 0 of the 46 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
171 vote records from 127 filers. 9 of the 125 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
78 vote records from 46 filers. 0 of the 46 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | For | For |
| BlackRock and iShares | Split or no vote | For | For |
| Fidelity | For | For | For |
| State Street and SPDR | For | For | For |
| American Century | For | For | For |
| Invesco | No report | For | No report |
| Equitable | For | For | For |
| Charles Schwab | For | For | For |
| Nuveen and TIAA | Split or no vote | For | For |
| ProShares and ProFunds | For | For | For |
| John Hancock and Manulife | For | For | For |
| Morgan Stanley, Eaton Vance and Calvert | Split or no vote | For | For |
| J.P. Morgan | No report | Against * | No report |
| Goldman Sachs | No report | For | No report |
| PGIM and Prudential | No report | For | No report |
| Northern Trust and FlexShares | Split or no vote | For | For |
| SEI | No report | For | No report |
| T. Rowe Price | For | For | For |
| Lincoln Financial | For | For | For |
| Voya | For | For | For |
| Nationwide | For | For | For |
| Victory Capital | For | For | For |
| Guggenheim and Rydex | For | For | For |
| Columbia Threadneedle | For | For | For |
| BNY Mellon | No report | For | No report |
| Principal | No report | For | No report |
| Pacific Life funds | Split or no vote | For | For |
| Global X | For | For | For |
| AllianceBernstein | No report | For | No report |
| DWS | For | For | For |
| Neuberger Berman | No report | For | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Lifecore Biomedical, Inc. meeting?
128 Form N-PX filers reported votes at the meeting of 7 Nov 2024. On say-on-pay, 9 of 125 voted against management (7.2%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Lifecore Biomedical, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Lifecore Biomedical, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Lifecore Biomedical, Inc. with a meeting date within three days of 7 Nov 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.